Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,615 Shares

Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern sold 3,615 shares of the stock in a transaction on Friday, July 5th. The stock was sold at an average price of $7.18, for a total transaction of $25,955.70. Following the sale, the vice president now directly owns 74,563 shares in the company, valued at $535,362.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Arteris Stock Up 4.1 %

AIP opened at $8.05 on Friday. The company has a market cap of $309.76 million, a PE ratio of -7.82 and a beta of 1.11. Arteris, Inc. has a twelve month low of $4.20 and a twelve month high of $9.54. The company has a 50-day moving average price of $7.95 and a 200 day moving average price of $7.02. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.11.

Arteris (NASDAQ:AIP) last announced its earnings results on Thursday, May 2nd. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The company had revenue of $12.95 million during the quarter, compared to analyst estimates of $12.60 million. Arteris had a negative net margin of 69.70% and a negative return on equity of 198.35%. Sell-side analysts expect that Arteris, Inc. will post -0.91 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Rosenblatt Securities reissued a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Friday, May 3rd. Jefferies Financial Group reiterated a “hold” rating and set a $9.00 price target (down previously from $11.00) on shares of Arteris in a research report on Monday, May 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $13.40.

Institutional Trading of Arteris

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Acuitas Investments LLC boosted its position in shares of Arteris by 150.3% during the fourth quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock worth $1,272,000 after buying an additional 129,692 shares during the period. Worth Venture Partners LLC grew its position in Arteris by 114.3% in the 4th quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock valued at $647,000 after acquiring an additional 58,620 shares in the last quarter. Citigroup Inc. purchased a new stake in Arteris during the third quarter worth about $363,000. Victory Capital Management Inc. acquired a new stake in shares of Arteris during the fourth quarter worth about $60,000. Finally, GSA Capital Partners LLP boosted its stake in shares of Arteris by 26.9% in the first quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock valued at $973,000 after purchasing an additional 28,165 shares during the period. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.